by PRI | Jan 22, 2024 | Microbiome Research & Technology (public)
Chun-Ying Wu Chair The Taiwan Microbiota Consortium consists of a group of government-related management unit personnel, medical professionals, biotech and pharmaceutical industry representatives, and academic research experts, etc., who jointly form a cross-field,...
by PRI | Jan 17, 2024 | News & Events
The Pharmabiotics Conference Advisory Committee with the PRI Team and I-Squared Media are pleased to announce the upcoming 9th edition of the annual Pharmabiotics Conference & Partnering Event, 12-14 March, in Lille. This year’s theme, ‘An Evolving Regulatory...
by PRI | Jan 16, 2024 | Microbiome Product Developer
Sandrine Claus Founder & CEO STARFISH Bioscience specializes in the innovation and development of microbiological solutions for agriculture and viticulture.Our mission is to regenerate soils through the restoration of their microbiomes to improve sustainability...
by PRI | Jan 9, 2024 | Association Ambassadors
Mr. Joseph Simmons Joseph Simmons is the Operations Manager at the Pharmabiotic Research Institute (PRI)”Microbiome scientists and developers need to employ a comprehensive regulatory engagement strategy if their innovations are ever to have real societal...
by PRI | Dec 13, 2023 | News & Events
Next year PRI Microbiome Project Manager Céline Druart (PhD) will present at Hanson Wade’s Microbiome Movement Drug Development Europe 2024 event. Her presentation is titled “European Regulatory Developments: Uncovering the New SoHo Regulation &...
